MyriaMeat, a pioneering biotech startup based in Göttingen and Munich, has been recognized in the 2025 EY German Biotechnology Report — a significant milestone for the young company.
The 2025 EY report, created in collaboration with BIO Deutschland e.V., highlights the current challenges and opportunities in the biotech sector. Despite increasing difficulties in capital acquisition across the industry, MyriaMeat’s inclusion signals that cutting-edge developments in alternative proteins continue to attract strong interest. As biotechnology becomes more strategically important globally, MyriaMeat’s sustainable vision positions it as a leader in the future of food.

🌱 🥩 MyriaMeat had the honor of being one of the top 5 nominated startups in the young company category at the Innovation Prize of the Göttingen Northeim region made possible by the WRG Wirtschaftsförderung Region Göttingen GmbH.

We are excited to share that MyriaMeat attended the The International Scientific Conference on Cultured Meat (ISCCM) in Maastricht! 🌍🍖 Our teammember and scientific advisor Malte Tiburcy had the opportunity to connect with leading experts in the field, explore the latest advancements in cultured meat technology, and exchange ideas that are shaping the future of sustainable and ethical food production.

MyriaMeat Managing Director Gunther Zimmermann had the honor of taking part in a panel discussion at the 12th symposium of the AG Industrial Cell Technology – Innovative Biotechnology for a Sustainable Future – in Medicine, Bioproduction and Nutrition in the MUK Gallery Lübeck at the invitation of Prof. Charli Kruse .